THE BE T
Multimedia Highlights
From the CardioSource WorldNews YouTube Channel | Scan the QR code to watch the full video
The Diagnostic Odyssey of Patients
with Undetected AF: Advance in Ambulatory Monitoring
Judy Lenane (R), Executive VP (with Sunil Kumar
Agarwal, MD, PhD (L)): “We wanted to answer
the question, ‘Once a patient has an index Holter,
what happens over a 2-year period[…] What we
actually saw is that patients get repeated Holters
over and over. And we know that a Holter, on its
own, is only a 15% diagnostic yield. So you’re not
getting an answer.”
The First Decade of Appropriate Use
Criteria (AUC) for Cardiac Imaging
Todd D. Miller, MD: “[With the criteria in place]
you have a little bit of improvement in appropriate studies, [and] some increase in inappropriate
studies. I think that indicates that maybe we’re
able to categorize studies more effectively. But
it really doesn’t seem to be changing physician
behavior.”
New Perspectives on Prevalence and
Mortality Related to Hypertrophic
Cardiomyopathy
Barry J. Maron, MD: “By establishing better
prevalence estimates… that underscores the
need to recognize that this is a common, treatable, contemporary disease that’s out there. And
if you expect to recognize it more frequently, the
chances are [that] you will[…] I think it’s about time
that there has been some optimism about this
disease.”
Arnold RJG, et al. JHEOR. 2015;2(2):161-9
Miller TD J, Askew JW. J Am Coll Cardiol.
2015;65(8):774-6.
Semsarian C, Ingles J, Maron MS, et al. J
Am Coll Cardiol. 2015;65(12):1249-54.
Who Has HFpEF? Review of Trials
Finds Inconsistent Answers
Finally, Clarity in the Duel over Optimal DAPT Duration
CRYSTAL AF: Real-world Stud